Rapid Nutrition PLC ("Rapid Nutrition" or the "Company") Results of General Meeting 2024
London, United Kingdom - 10 January, 2024 – Rapid Nutrition PLC (Euronext Growth: ALRPD), a natural wellness company focused on evidenced-based nutrition and herbal products, announces that the general meeting (the “General Meeting”) has been held on 10 January 2024 at 10:00 pm (UK Time) / 8:00 am (Australian Eastern Standard Time) on 11 January 2024.
All resolutions as set out in the notice dated 13 December 2023 and put to the General Meeting were duly passed. In accordance with best practice, votes in respect of all resolutions were cast by way of poll, the results of which are set out below:
| RESOLUTIONS | For | Against | Vote withheld | |
|
|
Subject to the passing or resolution 4, to approve the consolidation and subdivision of the ordinary shares. | 536,120,582 | 0 | 0 |
|
|
To confer on the directors authority to allot securities in accordance with section 551 of the Companies Act 2006. | 536,120,582 | 0 | 0 |
|
|
Subject to the passing of resolution 2, to confer on the directors the power to allot securities under a disapplication of section 561 of the Companies Act 2006. | 536,120,582 | 0 | 0 |
|
|
To adopt new articles of association of the Company. | 536,120,582 | 0 | 0 |
|
|
To authorise the Company to make one or more market purchases of New Ordinary Shares. | 536,120,582 | 0 | 0 |
Pursuant to the Reorganisation, 195 additional ordinary shares issued at par value will be admitted to Euronext on the 11th January, 2024 and the consolidation and subdivision of the ordinary shares will take effect on the 12th January 2024 under the new ISIN GB00BM9PTW47. Following the Reorganisation, if banks encounter fractional shares after the recording of the operation for their clients, common practice is that they will retain and likely sell them independently.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).